Related Experiment Video
Updated: Jan 21, 2026

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
Published on: October 12, 2018
Management of human immunodeficiency virus-associated cryptococcal meningitis: Current status and future directions
1Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Abstract:
Cryptococcal meningitis (CM) is one of the most common opportunistic infections of acquired immunodeficiency syndrome (AIDS), as well as an important cause of hospitalisation and death. In recent years, the mortality of CM has remained high in HIV/AIDS population, with up to 30%, including within developed countries. The treatment usually encompasses controls of Cryptococcus, HIV, and increased intracranial pressure. Recent progress on the management of HIV-associated CM mainly centres in optimising induction regimens, looking for appropriate timing of initiating antiretroviral therapy and prevention of symptomatic onset and adverse consequences. This review compared several international guidelines combined with the results from some clinical researches to illustrate the similarities, differences and potential in CM treatment. The present practice is still far from satisfactory, and there remains much to explore due to our limited understanding of the pathogenesis of HIV-associated CM. Thus, screening and monitoring should be strengthened, and better therapies in line with the actual situation of each country should be discovered.
Insights
Cryptococcal meningitis (CM) remains a deadly opportunistic infection for people with HIV/AIDS, with high mortality rates. Improved screening, monitoring, and novel therapies are crucial for better management of this serious condition.
Area of Science:
- Infectious Diseases
- Immunology
- Neurology
Background:
- Cryptococcal meningitis (CM) is a leading opportunistic infection in individuals with acquired immunodeficiency syndrome (AIDS).
- Despite advances, CM continues to have a high mortality rate, up to 30%, even in developed countries.
- Current treatment strategies involve managing Cryptococcus, HIV, and intracranial pressure.
Purpose of the Study:
- To review and compare international guidelines and clinical research on managing HIV-associated CM.
- To identify similarities, differences, and future potential in CM treatment strategies.
- To highlight the need for improved understanding and therapeutic approaches for HIV-associated CM.
Main Methods:
- Comparative analysis of international CM management guidelines.
- Review of recent clinical research findings on HIV-associated CM.
- Synthesis of current knowledge on CM pathogenesis and treatment.
Main Results:
- Treatment of HIV-associated CM focuses on optimizing induction regimens and antiretroviral therapy timing.
- Significant challenges persist due to incomplete understanding of CM pathogenesis.
- Current treatment practices are considered suboptimal, necessitating further research and development.
Conclusions:
- There is a critical need to strengthen screening and monitoring for CM in HIV/AIDS patients.
- Development of novel, country-specific therapies is essential for improving outcomes.
- Further research into the pathogenesis of HIV-associated CM is required to advance treatment options.
Related Concept Videos
Cranial and Spinal Meninges
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
What are Viruses?
Marcia's Theory of Identity Status
Electrical Current
Significance of Displacement Current

